The hungry stomach: physiology, disease and drug development opportunities

During hunger, a series of high-amplitude contractions of the stomach and small intestine (phase III), which form part of a cycle of quiescence and contractions (known as the migrating motor complex; MMC), play a 'housekeeping' role prior to the next meal and may contribute towards the dev...

Full description

Saved in:
Bibliographic Details
Main Authors: Gareth J Sanger (Author), Per M Hellström (Author), Erik eNäslund (Author)
Format: Book
Published: Frontiers Media S.A., 2011-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dc680dbb6ba2409b8e90fa538bb9b6d2
042 |a dc 
100 1 0 |a Gareth J Sanger  |e author 
700 1 0 |a Per M Hellström  |e author 
700 1 0 |a Erik eNäslund  |e author 
245 0 0 |a The hungry stomach: physiology, disease and drug development opportunities 
260 |b Frontiers Media S.A.,   |c 2011-02-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2010.00145 
520 |a During hunger, a series of high-amplitude contractions of the stomach and small intestine (phase III), which form part of a cycle of quiescence and contractions (known as the migrating motor complex; MMC), play a 'housekeeping' role prior to the next meal and may contribute towards the development of hunger. Several gastrointestinal hormones are associated with phase III MMC activity, but currently the most prominent is motilin, thought to at least partly mediate phase III contractions of the gastric MMC. Additional GI endocrine and neuronal systems play even more powerful roles in the development of hunger. In particular, the ghrelin-precursor gene is proving to have a complex physiology, giving rise to three different products: ghrelin itself, which is formed from a post translational modification of des-acyl-ghrelin, and obestatin. The receptors acted on by des-acyl-ghrelin and by obestatin are currently unknown but both these peptides seem able to exert actions which oppose that of ghrelin, either indirectly or directly. An increased understanding of the actions of these peptides is helping to unravel a number of different eating disorders and providing opportunities for the discovery of new drugs to regulate dysfunctional gastric behaviours and appetite. To date, ghrelin and motilin receptor agonists and antagonists have been described. The most advanced are compounds which activate the ghrelin and motilin receptors which are being progressed for disorders associated with gastric hypomotility. 
546 |a EN 
690 |a Ghrelin 
690 |a Motilin 
690 |a Stomach 
690 |a Des-acyl-ghrelin 
690 |a Migrating Motor Complex 
690 |a Obestatin 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 1 (2011) 
787 0 |n http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00145/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/dc680dbb6ba2409b8e90fa538bb9b6d2  |z Connect to this object online.